Target- |
MechanismImmunostimulants |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.Austria |
First Approval Date01 Feb 2014 |
100 Clinical Results associated with Fbm-Pharma
0 Patents (Medical) associated with Fbm-Pharma
100 Deals associated with Fbm-Pharma
100 Translational Medicine associated with Fbm-Pharma